Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6226332

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
1 167 910 PLN
124 909 869 PLN
Other income
292 435 PLN
3 696 PLN
Profit (loss) from operating activities
13 764 299 PLN
73 704 195 PLN
Finance income
786 589 PLN
889 653 PLN
Finance costs
658 609 PLN
939 716 PLN
Profit (loss) before tax
13 636 319 PLN
73 654 132 PLN
Tax expense (income)
0 PLN
5 691 500 PLN
Profit (loss) from continuing operations
13 636 319 PLN
67 962 632 PLN
Profit (loss) from discontinued operations
0 PLN
0 PLN
Profit (loss)
0 PLN
0 PLN
0 PLN
0 PLN
13 636 319 PLN
13 636 319 PLN
13 636 319 PLN
67 962 632 PLN
0 PLN
67 962 632 PLN
0 PLN
0 PLN
67 962 632 PLN
0 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
13 636 319 PLN
67 962 632 PLN
Profit (loss), attributable to non-controlling interests
0 PLN
0 PLN
Earnings per share [text block]
Zysk na akcję
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
98.00
500.00
Basic earnings (loss) per share from discontinued operations
0.00
0.00
Basic earnings (loss) per share
98.00
500.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
98.00
490.00
Diluted earnings (loss) per share from discontinued operations
0.00
0.00
Diluted earnings (loss) per share
98.00
490.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.